StockNews.com Downgrades ACADIA Pharmaceuticals (NASDAQ:ACAD) to Hold
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Monday. ACAD has been the subject of several other research reports. HC Wainwright restated a “buy” rating and issued a $27.00 price objective on shares of ACADIA Pharmaceuticals in a research […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Monday. ACAD has been the subject of several other research reports. HC Wainwright restated a “buy” rating and issued a $27.00 price objective on shares of ACADIA Pharmaceuticals in a research […]
